Eupraxia Pharmaceuticals (EPRX) Long-Term Debt Repayments (2023 - 2026)
Eupraxia Pharmaceuticals (EPRX) reported Long-Term Debt Repayments of -$82,004 for the quarter ended Jun 30, 2026, compared with -$21,117 a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Long-Term Debt Repayments (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Eupraxia Pharmaceuticals' Long-Term Debt Repayments came in at -$165,970; for the year ended Dec 31, 2025, it was -$83,671.
- By year, Long-Term Debt Repayments came in at -$62,651 in the year ended Dec 31, 2024, -$79,441 in the year ended Dec 31, 2023 and -$74,845 in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Long-Term Debt Repayments in data going back to the quarter ended Mar 31, 2023.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -$41,783 (quarter ended Mar 31, 2026), -$20,957 (quarter ended Dec 31, 2025) and -$21,226 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.00 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -2.45 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 17.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Eupraxia Pharmaceuticals | 363.60 Mn | 362.00 Mn | - | -82,004.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -82,004.00 |
| Mar 31, 2026 | -41,783.00 |
| Dec 31, 2025 | -20,957.00 |
| Sep 30, 2025 | -21,226.00 |
| Jun 30, 2025 | -21,117.00 |
| Mar 31, 2025 | -20,371.00 |
| Sep 30, 2024 | -21,262.00 |
| Jun 30, 2024 | -20,842.00 |
| Mar 31, 2024 | -20,547.00 |
| Dec 31, 2023 | -20,298.00 |
| Sep 30, 2023 | -19,992.00 |
| Jun 30, 2023 | -19,751.00 |
| Mar 31, 2023 | -19,400.00 |
API Access
Eupraxia Pharmaceuticals Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();